Complete genome sequence of MIDG2331, a genetically tractable serovar 8 clinical isolate of Actinobacillus pleuropneumoniae

Bossé, Janine T; Chaudhuri, Roy R.; Li, Yanwen; Leanse, Leon G.; Fernandez Crespo, Roberto; Coupland, Paul; Holden, Matthew T G; Bazzolli, Denise M.; Maskell, Duncan J.; Tucker, Alexander W.; Wren, Brendan W.; Rycroft, Andrew N.; Langford, Paul R.; BRaDP1T Consortium

View/Open

Boss_2016_GENOMEANNOUNC_CC_BY.pdf (156.0Kb)

Date

28/01/2016

Altmetrics Handle Statistics

Altmetrics DOI Statistics

Abstract

We report here the complete annotated genome sequence of a clinical serovar 8 isolate Actinobacillus pleuropneumoniae MIDG2331. Unlike the serovar 8 reference strain 405, MIDG2331 is amenable to genetic manipulation via natural transformation as well as conjugation, making it ideal for studies of gene function.

Citation

Bossé , J T , Chaudhuri , R R , Li , Y , Leanse , L G , Fernandez Crespo , R , Coupland , P , Holden , M T G , Bazzolli , D M , Maskell , D J , Tucker , A W , Wren , B W , Rycroft , A N , Langford , P R & BRaDP1T Consortium 2016 , ' Complete genome sequence of MIDG2331, a genetically tractable serovar 8 clinical isolate of Actinobacillus pleuropneumoniae ' , Genome Announcements , vol. 4 , no. 1 , e01667-15 . https://doi.org/10.1128/genomeA.01667-15

Publication

Genome Announcements

Status

Peer reviewed

DOI

https://doi.org/10.1128/genomeA.01667-15

ISSN

2169-8287

Type

Journal article

Rights

Description

Wellcome Trust provided funding to Paul Coupland and Matthew Holden under grant number 098051. Biotechnology and Biological Sci- ences Research Council (BBSRC) provided funding to Janine T. Bosse, Roy R. Chaudhuri, Yanwen Li, Leon G. Leanse, Roberto Fernandez Cre- spo, Paul Coupland, Matthew Holden, Denise Mara Soares Bazzolli, Dun- can J. Maskell, Dan Tucker, Brendan W. Wren, Andrew N. Rycroft, Paul R. Langford, and BraDP1t Consortium under grant numbers BB/ G020744/1, BB/G019177/1, BB/G019274/1, and BB/G018553/1. Biotech- nology and Biological Sciences Research Council (BBSRC) provided funding to Paul R Langford under grant number BB/K021109/1. MCTI | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) provided funding to Denise Mara Soares Bazzolli under grant number PDE 201840/2011-1. This work was supported by a Longer and Larger (LoLa) grant from the Biotechnology and Biological Sciences Research Council (grant numbers BB/G020744/1, BB/G019177/1, BB/G019274/1, and BB/G018553/1), the UK Department for Environment, Food and Rural Affairs, and Zoetis (formerly Pfizer Animal Health) awarded to the Bacterial Respiratory Dis- eases of Pigs-1 Technology (BRaDP1T) consortium, a grant from Con- selho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grant number PDE 201840/2011-1) awarded to D.M.B., and a BBSRC Imperial-Brazil partnering award (BB/K021109/1) awarded to P.R.L. M.T.G.H. and P.C. were supported by the Wellcome Trust (grant number 098051)

Collections

University of St Andrews Research

URI

http://hdl.handle.net/10023/8293